GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Gross-Profit-to-Asset %

Porton Pharma Solutions (SZSE:300363) Gross-Profit-to-Asset % : 6.50% (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Porton Pharma Solutions's annualized Gross Profit for the quarter that ended in Jun. 2024 was ¥588 Mil. Porton Pharma Solutions's average Total Assets over the quarter that ended in Jun. 2024 was ¥9,044 Mil. Therefore, Porton Pharma Solutions's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 6.50%.


Porton Pharma Solutions Gross-Profit-to-Asset % Historical Data

The historical data trend for Porton Pharma Solutions's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Gross-Profit-to-Asset % Chart

Porton Pharma Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.09 20.18 23.01 43.76 15.28

Porton Pharma Solutions Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.68 12.82 4.12 4.62 6.50

Competitive Comparison of Porton Pharma Solutions's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Porton Pharma Solutions's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's Gross-Profit-to-Asset % falls into.



Porton Pharma Solutions Gross-Profit-to-Asset % Calculation

Porton Pharma Solutions's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1492.204/( (10144.293+9384.029)/ 2 )
=1492.204/9764.161
=15.28 %

Porton Pharma Solutions's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=588.28/( (9212.265+8875.511)/ 2 )
=588.28/9043.888
=6.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Porton Pharma Solutions Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions Headlines

No Headlines